Fair Value Calculator Fair Value Calculator
EN DE

ULTRACAB (ULTRACAB) Fair Value & Analysis

IN · Market cap ₹906M

U ULTRACAB ULTRACAB · BSE
Price₹7.37
Fair Value₹9.09
Upside+23.3%
Quality40/100
Watch ULTRACAB for free — get notified when fair value or trend changes. Watch for free
Evidence: High Range ₹6.22 – ₹11.36

Fair value as of: Jul 6, 2026

From 23 valuation models · updated today

Share price +1.9% over the past month.

Price vs Fair Value (12 months)

₹11.35 ₹5.44 Fair Value ₹9.09 Jul 2025 Jul 2026

12‑month range ₹5.44 – ₹11.35 · fair‑value band ₹6.22 – ₹11.36 · the ₹7.37 price screens below the ₹9.09 fair value. As of Jul 6, 2026.

✦ Which stocks are undervalued right now? Check free Discover now →

Analysis

ULTRACAB (ULTRACAB) currently trades at ₹7.37, while our model-based Fair Value estimate is ₹9.09 — implying the stock looks roughly 23.3% undervalued today. We read business quality at 40/100 (below-average quality). Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.

Over the trailing twelve months, ULTRACAB generated revenue of ₹2.6B at a net margin of 2.2%. Revenue grew 9.5% year over year. It earns a return on equity of 6.2%. Net debt stands at ₹380M. Fundamentals as of Jul 6, 2026

Our scenario range runs from ₹6.22 (bear case) to ₹11.36 (bull case); at ₹7.37, the current price sits within that range. The share trades about 38% below its 52-week high and 40% above its 52-week low, currently below its 200-day average.

Key figures & financial health

Revenue (TTM) ₹2.6B
Revenue growth (YoY) +9.5%
Net margin 2.2%
Return on equity 6.2%
Free cash flow ₹21.7M FY2025
P/E ratio 16.4
More key figures
Operating margin 2.7%
EPS (TTM) ₹0.4500
EPS growth (YoY) -50.0%
Net debt ₹380M FY2025

Figures from reported company fundamentals (EODHD) · as of Jul 6, 2026. TTM = trailing twelve months.

Revenue & earnings trend

FY2021 – FY2025 · reported fiscal years

ULTRACAB reported revenue of ₹2.6B in FY2025 versus ₹851M in FY2021, a compound +32.2%/yr. Reported net income was ₹55.9M in FY2025, compounding +15.5%/yr from FY2021.

Revenue +32.2%/yr
FY21 ₹851M
FY22 ₹1.1B
FY23 ₹1.2B
FY24 ₹2.4B
FY25 ₹2.6B
Net income +15.5%/yr
FY21 ₹31.4M
FY22 ₹58.2M
FY23 ₹59.8M
FY24 ₹97.2M
FY25 ₹55.9M

Is ULTRACAB fairly valued? → Check now

🧮 Run the numbers yourself — free valuation calculators
📤 Share or link this analysis
🔗 Embed on your site (free fair-value badge)

Paste this into your site or blog — it shows the current fair value and links back here (free, and welcome):

Cite: Fair Value Calculator (2026). "ULTRACAB Fair Value". https://www.fairvalue-calculator.com/stock/ULTRACAB

Explore undervalued stocks

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued Blue-Chip StocksUndervalued Small-Cap Stocks

Frequently asked questions

Is ULTRACAB (ULTRACAB) undervalued?
As of Jul 6, 2026, our model estimates a fair value of ₹9.09 versus a price of ₹7.37 — about +23% (undervalued). Model-based estimate, not financial advice.
What is the fair value of ULTRACAB?
Our model-based fair value for ULTRACAB is ₹9.09 (as of Jul 6, 2026), built from audited fundamentals. The current price is ₹7.37.
What is the quality score of ULTRACAB?
ULTRACAB has a Quality Score of 40/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.
What is the revenue of ULTRACAB (ULTRACAB)?
ULTRACAB reported trailing-twelve-month revenue of about ₹2.6B (latest available figure, as of Jul 6, 2026).
What is the net profit margin of ULTRACAB?
The net profit margin of ULTRACAB is about 2.2%, meaning it keeps roughly 2.2% of revenue as net income. Based on the latest reported figures.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.